Open tender · Germany · Pharmaceutical products
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Glatirameracetat (ATC-Code: L03AX13), mit Ausnahme der Darreichungsform Fertigpen (PEN)
In EnglishConclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for pharmaceutical products containing the active ingredient glatiramer acetate (ATC code: L03AX13), with the exception of the pre-filled pen (PEN) pharmaceutical form
AOK Niedersachsen. Die Gesundheitskasse.
AOK Niedersachsen. Die Gesundheitskasse. in Germany is inviting bids for “Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for pharmaceutical products containing the active ingredient…”. Bids close on 27 November 2027, 12:00 CET. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Conclusion of a non-exclusive discount contract for the active substance Glatirameracetat (ATC-Code: L03AX13), excluding the pen form, from 01.02.2026 to 31.01.2028 in an 'open-house model'.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences